Photo of Kelly E. Irwin,  MD, MPH

Kelly E. Irwin, MD, MPH

Massachusetts General Hospital

Massachusetts General Hospital
Phone: (617) 643-4453
Fax: (617) 643-9913


kirwin@mgh.harvard.edu

Kelly E. Irwin, MD, MPH

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Instructor, Psychiatry, Harvard Medical School
  • Director, Collaborative Care and Community Engagement Program, Psychiatric Oncology and Behavioral Sciences, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dr. Irwin’s research interests focus on understanding health disparities for individuals with serious mental illness (SMI). Dr. Irwin is interested in understanding why people with SMI including schizophrenia and bipolar disorder are more likely to die from cancer and in developing interventions to improve cancer outcomes throughout the continuum of cancer care including prevention, early detection, treatment, and end-of-life care. She is investigating communication about smoking cessation, perceptions of cancer risk, and cancer screening in individuals with schizophrenia. She conducted a retrospective cohort study investigating inequities in cancer treatment for patients with severe mental illness and completed a qualitative study of oncology and mental health clinicians examining barriers to cancer care for people with schizophrenia. With support from the American Cancer Society, she piloted an intervention incorporating proactive psychiatry consultation and case management for individuals with severe mental illness and cancer and is now preparing to lead a follow-up randomized trial.

Publications

Powered by Harvard Catalyst
  • Irwin KE. The Patients We Have to See. Oncologist 2017. PubMed
  • Irwin KE, Park ER, Shin JA, Fields LE, Jacobs JM, Greer JA, Taylor JB, Taghian AG, Freudenreich O, Ryan DP, Pirl WF. Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia. Oncologist 2017. PubMed
  • Hagan TL, Fishbein JN, Nipp RD, Jacobs JM, Traeger L, Irwin KE, Pirl WF, Greer JA, Park ER, Jackson VA, Temel JS. Coping in Patients With Incurable Lung and Gastrointestinal Cancers: A Validation Study of the Brief COPE. J Pain Symptom Manage 2016; 53:131-138. PubMed
  • Irwin KE, Freudenreich O, Peppercorn J, Taghian AG, Freer PE, Gudewicz TM. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 30-2016. N Engl J Med 2016; 375:1270-81. PubMed
  • Pirl WF, Greer JA, Irwin K, Lennes IT, Jackson VA, Park ER, Fujisawa D, Wright AA, Temel JS. Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of life. J Oncol Pract 2015. PubMed
  • Irwin KE, Henderson DC, Knight HP, Pirl WF. Cancer care for individuals with schizophrenia. Cancer 2014; 120:323-34. PubMed
  • Irwin KE, Greer JA, Khatib J, Temel JS, Pirl WF. Early palliative care and metastatic non-small cell lung cancer: potential mechanisms of prolonged survival. Chron Respir Dis 2013; 10:35-47. PubMed
  • Wolfe J, Hammel JF, Edwards KE, Duncan J, Comeau M, Breyer J, Aldridge SA, Grier HE, Berde C, Dussel V, Weeks JC. Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol 2008; 26:1717-23. PubMed
  • Edwards KE, Neville BA, Cook EF Jr, Aldridge SH, Dussel V, Wolfe J. Understanding of prognosis and goals of care among couples whose child died of cancer. J Clin Oncol 2008; 26:1310-5. PubMed